Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Vera Therapeutics

    Client Virtual Booth

    VERA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Vera Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    170 Harbor Way, 3rd Floor South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 770-0077
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://veratx.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/07/05/2909190/0/en/Vera-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Jul 2024
    Share Share
    Vera Therapeutics Appoints David L. Johnson As Chief Operating Officer
    Vera Therapeutics Appoints David L. Johnson As Chief Operating Officer

    https://www.globenewswire.com/news-release/2024/07/01/2906661/0/en/Vera-Therapeutics-Announces-Appointment-of-Industry-Veteran-David-L-Johnson-as-Chief-Operating-Officer.html

    GLOBENEWSWIRE
    01 Jul 2024
    Share Share
    Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
    Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

    https://www.globenewswire.com/news-release/2024/06/11/2897152/0/en/Vera-Therapeutics-Appoints-Christy-J-Oliger-to-Board-of-Directors.html

    GLOBENEWSWIRE
    11 Jun 2024
    Share Share
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/06/07/2895569/0/en/Vera-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Jun 2024
    Share Share
    Vera To Participate At Goldman Healthcare Conference
    Vera To Participate At Goldman Healthcare Conference

    https://www.globenewswire.com/news-release/2024/06/07/2895567/0/en/Vera-Therapeutics-to-Participate-in-the-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jun 2024
    Share Share
    Vera’ atacicept for treatment of IgAN receivesUS FDA breakthrough therapy desig.
    Vera’ atacicept for treatment of IgAN receivesUS FDA breakthrough therapy desig.

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169473&sid=2

    PHARMABIZ
    30 May 2024
    Share Share
    Vera Therapeutics: FDA Breakthrough Therapy For Atacicept In IgAN
    Vera Therapeutics: FDA Breakthrough Therapy For Atacicept In IgAN

    https://www.globenewswire.com/news-release/2024/05/28/2888945/0/en/Vera-Therapeutics-Receives-U-S-FDA-Breakthrough-Therapy-Designation-for-Atacicept-in-Immunoglobulin-A-Nephropathy-IgAN.html

    GLOBENEWSWIRE
    28 May 2024
    Share Share
    Vera Atacicept IgAN Phase 2b: 72-Week Egfr Hematuria Data At Era Congress
    Vera Atacicept IgAN Phase 2b: 72-Week Egfr Hematuria Data At Era Congress

    https://www.globenewswire.com/news-release/2024/05/25/2888237/0/en/Vera-Therapeutics-Presents-72-week-eGFR-Stabilization-and-Rapid-Hematuria-Improvement-in-Phase-2b-ORIGIN-Study-of-Atacicept-in-IgAN-at-the-61st-European-Renal-Association-Congress.html

    GLOBENEWSWIRE
    25 May 2024
    Share Share
    Vera Therapeutics Q1 2024 Results And Business Update
    Vera Therapeutics Q1 2024 Results And Business Update

    https://www.globenewswire.com/news-release/2024/05/09/2878707/0/en/Vera-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/05/07/2877292/0/en/Vera-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 May 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search